Yew Bio-Pharm Group, Inc. (YEWB) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
9460 TELSTAR AVENUE, SUITE 6 EL MONTE, CA 91731 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| Industry (SIC) | 01 - Agricultural Production Crops (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2021 MRQ | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 564 | 742 | 522 | 860 | 279 | 682 | |||
| Cash and cash equivalents | 564 | 742 | 522 | 860 | 279 | 682 | |||
| Restricted cash and investments | 304 | ||||||||
| Receivables | 274 | 8,042 | 1,003 | 11,609 | 23,066 | 11,047 | |||
| Inventory, net of allowances, customer advances and progress billings | 15 | 2,637 | 6,205 | 2,579 | 10,297 | 4,666 | |||
| Inventory | 15 | 2,637 | 6,205 | 2,579 | 10,297 | 4,666 | |||
| Other undisclosed current assets | 9,137 | 250 | 4,660 | 20,386 | 152 | 171 | |||
| Total current assets: | 9,989 | 11,671 | 12,389 | 35,434 | 33,793 | 16,868 | |||
| Noncurrent Assets | |||||||||
| Inventory, Noncurrent | 785 | 1,580 | 1,824 | 10,547 | 7,152 | 12,334 | |||
| Operating lease, right-of-use asset | 333 | 400 | ✕ | ✕ | ✕ | ✕ | |||
| Property, plant and equipment | 489 | 475 | 519 | 580 | 692 | 703 | |||
| Long-term investments and receivables | 1,185 | 930 | |||||||
| Due from related parties | 1,185 | 930 | |||||||
| Intangible assets, net (including goodwill), including: | 28 | 32 | 45 | 6,370 | 4,558 | 13,906 | |||
| Intangible assets, net (excluding goodwill) | 28 | 40,049 | 34,915 | 6,370 | 4,558 | 13,906 | |||
| Other undisclosed intangible assets, net (including goodwill) | (40,016) | (34,869) | |||||||
| Other undisclosed noncurrent assets | 46,822 | 38,864 | 33,985 | ||||||
| Total noncurrent assets: | 48,457 | 42,535 | 37,303 | 17,496 | 12,402 | 26,943 | |||
| TOTAL ASSETS: | 58,447 | 54,207 | 49,692 | 52,930 | 46,195 | 43,811 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 424 | 248 | 458 | 163 | 379 | 125 | |||
| Taxes payable | 116 | 190 | 6 | 17 | |||||
| Employee-related liabilities | 45 | ||||||||
| Accounts payable | 424 | 132 | 268 | ||||||
| Accrued liabilities | 80 | ||||||||
| Other undisclosed accounts payable and accrued liabilities | 157 | 363 | |||||||
| Debt | 8,980 | 8,594 | 5,759 | 6,100 | 2,880 | 3,688 | |||
| Due to related parties | 651 | 634 | 580 | 620 | 884 | 761 | |||
| Other undisclosed current liabilities | 470 | 1,006 | 265 | 516 | 3,355 | 67 | |||
| Total current liabilities: | 10,525 | 10,481 | 7,062 | 7,399 | 7,498 | 4,641 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation: | 292 | 351 | |||||||
| Liabilities, other than long-term debt | 2,147 | 892 | 360 | 121 | |||||
| Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | 360 | 121 | |||
| Accounts payable and accrued liabilities | 974 | ||||||||
| Deferred revenue | 1,173 | 892 | ✕ | ✕ | ✕ | ✕ | |||
| Operating lease, liability | 292 | 351 | ✕ | ✕ | ✕ | ✕ | |||
| Other undisclosed noncurrent liabilities | 1,088 | 1,543 | |||||||
| Total noncurrent liabilities: | 2,439 | 2,332 | 1,543 | 360 | 121 | ||||
| Total liabilities: | 12,964 | 12,813 | 8,605 | 7,758 | 7,619 | 4,641 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | 45,483 | 41,394 | 41,087 | 45,172 | 38,576 | 39,170 | |||
| Common stock | 52 | 52 | 52 | 52 | 52 | 52 | |||
| Additional paid in capital | 9,645 | 9,820 | 9,953 | 10,363 | 9,654 | 9,623 | |||
| Accumulated other comprehensive income (loss) | 608 | (2,191) | (1,646) | 707 | (1,967) | 666 | |||
| Retained earnings | 31,416 | 29,951 | 28,965 | 30,288 | 27,075 | 25,068 | |||
| Other undisclosed equity, attributable to parent | 3,762 | 3,762 | 3,762 | 3,762 | 3,762 | 3,762 | |||
| Total equity: | 45,483 | 41,394 | 41,087 | 45,172 | 38,576 | 39,170 | |||
| TOTAL LIABILITIES AND EQUITY: | 58,447 | 54,207 | 49,692 | 52,930 | 46,195 | 43,811 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2021 TTM | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 27,308 | 27,884 | 37,597 | 40,540 | 51,348 | 29,574 | ||
| Revenue, net | ✕ | ✕ | ✕ | ✕ | 40,540 | 51,348 | 29,574 | |
| Revenue from related parties | 26,418 | 17,850 | 37,166 | ✕ | ✕ | ✕ | ||
| Cost of revenue | (23,781) | (27,110) | (26,873) | (35,478) | (48,114) | (22,541) | ||
| Cost of goods and services sold | (10,003) | (1,241) | (17,811) | (24,689) | (11,104) | |||
| Gross profit: | 3,527 | 774 | 10,724 | 5,062 | 3,235 | 7,033 | ||
| Operating expenses | (958) | 237 | (10,006) | (1,737) | (1,113) | (1,893) | ||
| Operating income: | 2,569 | 1,012 | 719 | 3,325 | 2,121 | 5,140 | ||
| Nonoperating income (expense) | (1,075) | (15) | (548) | (111) | (96) | 161 | ||
| Investment income, nonoperating | 148 | |||||||
| Gain (loss), foreign currency transaction, before tax | (608) | 318 | (338) | |||||
| Other nonoperating income (expense) | 15 | 57 | 84 | (34) | 44 | 0 | ||
| Interest and debt expense | (482) | (390) | (294) | |||||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 1,279 | |||||||
| Income (loss) from continuing operations before equity method investments, income taxes: | 1,012 | 606 | (123) | 3,214 | 2,025 | 6,580 | ||
| Other undisclosed income (loss) from continuing operations before income taxes | 482 | 390 | 294 | (1,279) | ||||
| Income from continuing operations before income taxes: | 1,494 | 997 | 171 | 3,214 | 2,025 | 5,301 | ||
| Income tax expense | (29) | (11) | (1,493) | (1) | (18) | (16) | ||
| Income (loss) from continuing operations: | 1,465 | 986 | (1,322) | 3,213 | 2,007 | 5,285 | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | 1,465 | 986 | (1,322) | 3,213 | 2,007 | 5,285 | |
| Net income (loss) available to common stockholders, diluted: | 1,465 | 986 | (1,322) | 3,213 | 2,007 | 5,285 | ||
Comprehensive Income ($ in thousands)
| 9/30/2021 TTM | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | 1,465 | 986 | (1,322) | 3,213 | 2,007 | 5,285 | ||
| Comprehensive income (loss): | 1,465 | 986 | (1,322) | 3,213 | 2,007 | 5,285 | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 2,799 | (545) | (2,353) | 2,673 | (2,632) | (2,081) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | 4,264 | 441 | (3,675) | 5,886 | (625) | 3,204 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.